- Home
- TCRT vs SOBR Comparison
TCRT vs SOBR Comparison
Compare TCRT & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRT
- SOBR
- Stock Information
- Founded
- TCRT 1998
- SOBR 2004
- Country
- TCRT United States
- SOBR United States
- Employees
- TCRT N/A
- SOBR N/A
- Industry
- TCRT Biotechnology: Pharmaceutical Preparations
- SOBR Newspapers/Magazines
- Sector
- TCRT Health Care
- SOBR Consumer Discretionary
- Exchange
- TCRT Nasdaq
- SOBR Nasdaq
- Market Cap
- TCRT 5.5M
- SOBR 5.2M
- IPO Year
- TCRT N/A
- SOBR N/A
- Fundamental
- Price
- TCRT N/A
- SOBR N/A
- Analyst Decision
- TCRT
- SOBR
- Analyst Count
- TCRT 0
- SOBR 0
- Target Price
- TCRT N/A
- SOBR N/A
- AVG Volume (30 Days)
- TCRT 47.7K
- SOBR 14.9K
- Earning Date
- TCRT 11-13-2025
- SOBR 11-13-2025
- Dividend Yield
- TCRT N/A
- SOBR N/A
- EPS Growth
- TCRT N/A
- SOBR N/A
- EPS
- TCRT N/A
- SOBR N/A
- Revenue
- TCRT $6,000.00
- SOBR $301,400.00
- Revenue This Year
- TCRT $5,680,500.00
- SOBR N/A
- Revenue Next Year
- TCRT N/A
- SOBR N/A
- P/E Ratio
- TCRT N/A
- SOBR N/A
- Revenue Growth
- TCRT N/A
- SOBR 73.21
- 52 Week Low
- TCRT $1.31
- SOBR $2.41
- 52 Week High
- TCRT $6.20
- SOBR $193.50
- Technical
- Relative Strength Index (RSI)
- TCRT 66.77
- SOBR 43.87
- Support Level
- TCRT $2.44
- SOBR $3.18
- Resistance Level
- TCRT $3.17
- SOBR $3.35
- Average True Range (ATR)
- TCRT 0.19
- SOBR 0.12
- MACD
- TCRT 0.06
- SOBR -0.00
- Stochastic Oscillator
- TCRT 81.81
- SOBR 20.51
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.